 Effects long-term zidovudine treatment cell-mediated immune response lymphokine production effects long-term zidovudine treatment functional parameters cell-mediated immunity symptomatic HIV-antibody-positive patients clinical evidence opportunistic infections Mononuclear leukocytes drug months treatment cells lectins order variations mitogen-induced lymphocyte proliferation production gamma-interferon IFN Newcastle disease virus NDV variations alpha-IFN production Mean proliferative responses PHA Con-A significant change baseline months months values D-cpm PHA D-cpm Con-A Mean response PWM D-cpm entry months values months D-cpm production I.U entry months levels months contrast moderate significant decrease gamma- alpha-IFN production gamma-IFN alpha-IFN